Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01034670
Other study ID # IRB-15766
Secondary ID NCI-2021-03446U5
Status Recruiting
Phase N/A
First received
Last updated
Start date June 2009
Est. completion date December 2025

Study information

Verified date February 2024
Source Stanford University
Contact Cancer Clinical Trials Office
Phone (650) 498-7061
Email ccto-office@stanford.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To develop new methods to detect malignant and premalignant conditions of the gastrointestinal tract.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date December 2025
Est. primary completion date December 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:patients be at least 18 years of age, Either genders All ethnic backgrounds will be considered. Patients who are scheduled for endoscopy by one of the investigators will be asked if they are interested in participating in the study. The study will be open to all patients undergoing endoscopy that do not have exclusion criteria. We will ask all patients if they are participating in any other studies. If they are participating in any other study then we will ask them for more information to determine whether there could be any harm from participating in both studies and if there is then they will not be enrolled. Exclusion Criteria:Patients with unstable vital signs will not be included.

Study Design


Intervention

Device:
Dual axis endoscopic microscope
This is a device that is used in the accessory port of a standard endoscope and allows visualization of microscopic areas of mucosa.
wide field fluorescence system
This is a modification to the existing narrow band endoscope from Olympus that incorporates different filters on the source and collecting optics to enable fluorescence imaging. It is used as is a standard endoscope.
CellVizio
Minimicroscope--this is an FDA approved fiber-based microscope that we will use according to the manufacturers protocols.
Drug:
fluorescent Peptide
microdosing; Topical through the endoscope
fluorescein
100 mcg topical
indocyanine green
100 mcg topical

Locations

Country Name City State
United States Stanford University School of Medicine Stanford California

Sponsors (3)

Lead Sponsor Collaborator
Stanford University National Cancer Institute (NCI), National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Detection of neoplasia 5 years
See also
  Status Clinical Trial Phase
Terminated NCT02541357 - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery N/A
Active, not recruiting NCT02358122 - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh N/A
Active, not recruiting NCT02442115 - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation NCT00943345 - Validation of New Tests for Gastrointestinal (GI) Permeability Phase 0
Completed NCT00612404 - Symptoms and Endoscopic Results in Consideration of Pretreatment N/A
Completed NCT01127711 - Cohort of Swedish Men N/A
Recruiting NCT05712525 - Gut Recovery In Patients Following Surgery
Recruiting NCT06094153 - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function N/A
Recruiting NCT05322486 - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed NCT02486146 - GI Biorepository of Tissue and Bodily Fluids N/A
Completed NCT01816607 - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed NCT00247715 - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study) N/A
Completed NCT00035334 - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis Phase 2/Phase 3
Recruiting NCT06286865 - Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial N/A
Active, not recruiting NCT01037049 - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks Phase 2
Completed NCT03725813 - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit N/A
Recruiting NCT05640401 - Holographic Screens as a Replacement of Monitors During GI Endoscopies N/A
Completed NCT02865564 - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics N/A
Completed NCT02651857 - Exploratory Study of Upper and Lower Endoscopic Fuse System N/A
Active, not recruiting NCT01984034 - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines N/A